IPSC
Century Therapeutics, Inc.
There isn't enough reported data to score IPSC yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
IPSC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Unavailable | |
| Unavailable |
IPSC's revenue is currently healthy, but its profitability is weak. There isn't enough data to rate its cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
IPSC PE Valuation
IPSC has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
IPSC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect IPSC's losses to shrink, with revenue declining.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
IPSC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.64 | -$0.34 |
| Q2 2026 | -$0.93 | -$0.66 |
| Q1 2026 | -$1.14 | -$0.87 |
| Q4 2025 | -$0.14 | +$1.47 |
| Q3 2025 | -$0.30 | +$1.53 |
| Q2 2025 | -$0.27 | +$1.74 |
| Q1 2025 | -$0.27 | +$1.92 |
| Q4 2024 | -$1.61 | +$0.66 |
IPSC is still losing money, but far less than before: $0.64 per share over the past year, against $3.11 at its worst in late 2021.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over IPSC on earnings quality, reporting a profit while its opponent remains loss making.
IPSC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2025 | $109.2M | +12668% |
| Q4 2024 | $4.2M | +1457% |
| Q3 2024 | $791K | +434% |
| Q2 2024 | $771K | +679% |
| Q1 2024 | $855K | -50% |
| Q4 2023 | $268K | -49% |
| Q3 2023 | $148K | -93% |
| Q2 2023 | $99K | -93% |
UNH has the stronger quarterly revenue trend. Revenue is down 100% for IPSC versus down 0.4% for UNH.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2025 | 68% | +3730 points |
| Q4 2024 | -893% | +15436 points |
| Q3 2024 | -4398% | +19674 points |
| Q2 2024 | -4508% | +30924 points |
| Q1 2024 | -3662% | -1797 points |
| Q4 2023 | -16329% | -9936 points |
| Q3 2023 | -24072% | -22645 points |
| Q2 2023 | -35431% | -33186 points |
IPSC's operating margin was 68% last quarter, up 3730 points from the same quarter a year ago, near the top of its range since 2022.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
IPSC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$22.8M | +$3M |
| Q2 2026 | -$20.5M | +$7.4M |
| Q1 2026 | -$25.8M | +$9.3M |
| Q2 2025 | -$27.9M | -$312K |
| Q1 2025 | -$35.1M | -$4.3M |
| Q2 2024 | -$27.6M | -$3.8M |
| Q1 2024 | -$30.8M | +$3.4M |
| Q4 2023 | -$27.2M | +$2M |
IPSC has burned cash in almost every quarter: −$85M over the past year, against −$116M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over IPSC on cash generation, producing positive trailing cash flow while its opponent burns cash.
IPSC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +661K shares |
| 1 year | +139% | +120M shares |
| 3 years | +248% | +147M shares |
| 5 years | +277% | +152M shares |
| Available history | +394% | +165M shares |
IPSC has 206M diluted shares, up 139% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over IPSC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
IPSC Net Leverage
IPSC's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
IPSC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.8 | Neutral |
| Stochastic | 36.3 | Neutral |
IPSC's weekly RSI is 44 (neutral) and its Stochastic is 36 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
IPSC PE vs Healthcare Sector
IPSC has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
IPSC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.54 | 5.8% above |
| 20 week MA | $1.86 | 12% below |
| 50 week MA | $1.94 | 16% below |
| 100 week MA | $1.28 | 27% above |
| 200 week MA | $2.06 | 21% below |
IPSC's trend is mixed: it's above two of its five weekly moving averages, and 21% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over IPSC on trend strength, trading above more of its moving averages.
IPSC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $22.8 | $18.2 | -20% |
| 2022 | $18.2 | $5.67 | -69% |
| 2023 | $5.67 | $3.32 | -41% |
| 2024 | $3.32 | $1.04 | -69% |
| 2025 | $1.04 | $1.09 | +4.8% |
| 2026 YTD | $1.09 | $1.63 | +50% |
IPSC has the edge over UNH on returns for 2026, with the stronger performance.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has finished three years in a row lower, and it's up 22% so far in 2026.